Analysis of S100A4 expression in human breast cancers showed that its levels were higher in tumors carrying PIK3CA H1047R or TP53 R270H or both compared to tumors without these mutations (Additional file 1: Figure S8). The gene discussed is PIK3CA; the disease is breast carcinoma.